{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["IL-38", "ILC2s", "Tregs", "allergic asthma", "eosinophils"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31645649", "DateCompleted": {"Year": "2021", "Month": "07", "Day": "28"}, "DateRevised": {"Year": "2024", "Month": "03", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "10", "Day": "23"}], "Language": ["eng"], "ELocationID": ["10.1038/s41423-019-0300-7"], "Journal": {"ISSN": "2042-0226", "JournalIssue": {"Volume": "17", "Issue": "6", "PubDate": {"Year": "2020", "Month": "Jun"}}, "Title": "Cellular & molecular immunology", "ISOAbbreviation": "Cell Mol Immunol"}, "ArticleTitle": "Anti-inflammatory mechanisms of the novel cytokine interleukin-38 in allergic asthma.", "Pagination": {"StartPage": "631", "EndPage": "646", "MedlinePgn": "631-646"}, "Abstract": {"AbstractText": ["We elucidated the anti-inflammatory mechanisms of IL-38 in allergic asthma. Human bronchial epithelial cells and eosinophils were cocultured upon stimulation with the viral RLR ligand poly (I:C)/LyoVec or infection-related cytokine TNF-\u03b1 to induce expression of cytokines/chemokines/adhesion molecules. House dust mite (HDM)-induced allergic asthma and humanized allergic asthma NOD/SCID murine models were established to assess anti-inflammatory mechanisms in vivo. IL-38 significantly inhibited induced proinflammatory IL-6, IL-1\u03b2, CCL5, and CXCL10 production, and antiviral interferon-\u03b2 and intercellular adhesion molecule-1 expression in the coculture system. Mass cytometry and RNA-sequencing analysis revealed that IL-38 could antagonize the activation of the intracellular STAT1, STAT3, p38 MAPK, ERK1/2, and NF-\u03baB pathways, and upregulate the expression of the host defense-related gene POU2AF1 and anti-allergic response gene RGS13. Intraperitoneal injection of IL-38 into HDM-induced allergic asthma mice could ameliorate airway hyperreactivity by decreasing the accumulation of eosinophils in the lungs and inhibiting the expression of the Th2-related cytokines IL-4, IL-5, and IL-13 in the bronchoalveolar lavage fluid (BALF) and lung homogenates. Histological examination indicated lung inflammation was alleviated by reductions in cell infiltration and goblet cell hyperplasia, together with reduced Th2, Th17, and innate lymphoid type 2 cell numbers but increased proportions of regulatory T cells in the lungs, spleen, and lymph nodes. IL-38 administration suppressed airway hyperreactivity and asthma-related IL-4 and IL-5 expression in humanized mice, together with significantly decreased CCR3<sup>+</sup> eosinophil numbers in the BALF and lungs, and a reduced percentage of human CD4<sup>+</sup>CRTH2<sup>+</sup> Th2 cells in the lungs and mediastinal lymph nodes. Together, our results demonstrated the anti-inflammatory mechanisms of IL-38 and provided a basis for the development of a regulatory cytokine-based treatment for allergic asthma."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong, China."}], "LastName": "Sun", "ForeName": "Xiaoyu", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong, China."}], "LastName": "Hou", "ForeName": "Tianheng", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancer Centre; Centre of Precision Medicine Research and Training, Faculty of Health Sciences, University of Macau, Macau, China."}], "LastName": "Cheung", "ForeName": "Edwin", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancer Centre; Centre of Precision Medicine Research and Training, Faculty of Health Sciences, University of Macau, Macau, China."}], "LastName": "Iu", "ForeName": "Tiffany Nga-Teng", "Initials": "TN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cancer Centre; Centre of Precision Medicine Research and Training, Faculty of Health Sciences, University of Macau, Macau, China."}], "LastName": "Tam", "ForeName": "Victor Wai-Hou", "Initials": "VW"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong, China."}], "LastName": "Chu", "ForeName": "Ida Miu-Ting", "Initials": "IM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong, China."}, {"Identifier": [], "Affiliation": "Institute of Chinese Medicine and State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Hong Kong, China."}], "LastName": "Tsang", "ForeName": "Miranda Sin-Man", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, The Chinese University of Hong Kong, Hong Kong, China."}], "LastName": "Chan", "ForeName": "Paul Kay-Sheung", "Initials": "PK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Medicine and State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau, China."}], "LastName": "Lam", "ForeName": "Christopher Wai-Kei", "Initials": "CW"}, {"Identifier": ["0000-0002-5637-8331"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong, China. ck-wong@cuhk.edu.hk."}, {"Identifier": [], "Affiliation": "Institute of Chinese Medicine and State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants, The Chinese University of Hong Kong, Hong Kong, China. ck-wong@cuhk.edu.hk."}, {"Identifier": [], "Affiliation": "Li Dak Sum Yip Yio Chin R & D Centre for Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, China. ck-wong@cuhk.edu.hk."}], "LastName": "Wong", "ForeName": "Chun-Kwok", "Initials": "CK"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "China", "MedlineTA": "Cell Mol Immunol", "NlmUniqueID": "101242872", "ISSNLinking": "1672-7681"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "0", "NameOfSubstance": "IL-38 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Inflammation Mediators"}, {"RegistryNumber": "0", "NameOfSubstance": "Interleukins"}, {"RegistryNumber": "0", "NameOfSubstance": "Ligands"}, {"RegistryNumber": "0", "NameOfSubstance": "Recombinant Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Tumor Necrosis Factor-alpha"}, {"RegistryNumber": "O84C90HH2L", "NameOfSubstance": "Poly I-C"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["complications", "drug therapy", "genetics", "immunology"], "DescriptorName": "Asthma"}, {"QualifierName": ["pathology"], "DescriptorName": "Bronchi"}, {"QualifierName": [], "DescriptorName": "Cells, Cultured"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Cytokines"}, {"QualifierName": ["drug effects"], "DescriptorName": "Down-Regulation"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Eosinophils"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Epithelial Cells"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression Regulation"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["complications", "drug therapy", "genetics", "immunology"], "DescriptorName": "Hypersensitivity"}, {"QualifierName": ["complications", "immunology", "pathology"], "DescriptorName": "Inflammation"}, {"QualifierName": ["metabolism"], "DescriptorName": "Inflammation Mediators"}, {"QualifierName": [], "DescriptorName": "Injections, Intraperitoneal"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Interleukins"}, {"QualifierName": [], "DescriptorName": "Ligands"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred BALB C"}, {"QualifierName": [], "DescriptorName": "Models, Biological"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Poly I-C"}, {"QualifierName": ["drug effects"], "DescriptorName": "Pyroglyphidae"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Recombinant Proteins"}, {"QualifierName": ["drug effects"], "DescriptorName": "Signal Transduction"}, {"QualifierName": ["drug effects", "immunology"], "DescriptorName": "T-Lymphocytes, Regulatory"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Tumor Necrosis Factor-alpha"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet. 2006;368:804\u2013813.", "ArticleIdList": ["16935691"]}, {"Citation": "Schatz M, Rosenwasser L. The allergic asthma phenotype. J. Allergy Clin. Immunol. Pract. 2019;2:645\u2013648.", "ArticleIdList": ["25439351"]}, {"Citation": "Foster PS, et al. Modeling TH2 responses and airway inflammation to understand fundamental mechanisms regulating the pathogenesis of asthma. Immunol. Rev. 2017;278:20\u201340.", "ArticleIdList": ["PMC5492958", "28658543"]}, {"Citation": "Matucci A, Vultaggio A, Maggi E, Kasujee I. Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question. Respir. Res. 2018;19:1\u201310.", "ArticleIdList": ["PMC5992661", "29879991"]}, {"Citation": "Mckenzie GJ, et al. Impaired development of Th2 cells in IL-13-deficient mice. Immunity. 1998;9:423\u2013432.", "ArticleIdList": ["9768762"]}, {"Citation": "Yang T, et al. Characteristics of proinflammatory cytokines and chemokines in airways of asthmatics: relationships with disease severity and infiltration of inflammatory cells. Chin. Med. J. (Engl.) 2017;130:2033\u20132040.", "ArticleIdList": ["PMC5586170", "28836545"]}, {"Citation": "Jartti T, Gern JE. Role of viral infections in the development and exacerbation of asthma in children. J. Allergy Clin. Immunol. 2018;140:895\u2013906.", "ArticleIdList": ["PMC7172811", "28987219"]}, {"Citation": "Hallstrand TS, et al. Airway epithelial regulation of pulmonary immune homeostasis and inflammation. Clin. Immunol. 2014;151:1\u201315.", "ArticleIdList": ["24503171"]}, {"Citation": "Possa SS, Leick EA, Prado CM, Martins MA. Tib\u00e9rio IFLC. Eosinophilic inflammation in allergic asthma. Front. Pharm. 2013;4:1\u20139.", "ArticleIdList": ["PMC3627984", "23616768"]}, {"Citation": "Fulkerson PC, Rothenberg ME. Targeting eosinophils in allergy, inflammation and beyond. Nat. Rev. Drug Discov. 2013;12:117\u2013129.", "ArticleIdList": ["PMC3822762", "23334207"]}, {"Citation": "Shamri R, Young KM, Weller PF. PI3K, ERK, p38 MAPK and integrins regulate CCR3-mediated secretion of mouse and human eosinophil-associated RNases. Allergy. 2013;68:880\u2013889.", "ArticleIdList": ["PMC3713189", "23742707"]}, {"Citation": "Wong CK, et al. NOD-like receptors mediated activation of eosinophils interacting with bronchial epithelial cells: a link between innate immunity and allergic asthma. Cell Mol. Immunol. 2013;10:317\u2013329.", "ArticleIdList": ["PMC4003204", "23524653"]}, {"Citation": "Zhu J, et al. Anti-allergic inflammatory activity of interleukin-37 is mediated by novel signaling cascades in human eosinophils. Front Immunol. 2018;9:1445.", "ArticleIdList": ["PMC6023969", "29988381"]}, {"Citation": "Jiao D, et al. Activation of eosinophils interacting with bronchial epithelial cells by antimicrobial peptide LL-37: implications in allergic asthma. Sci. Rep. 2017;4:1\u201313.", "ArticleIdList": ["PMC5431911", "28500314"]}, {"Citation": "Lin H, et al. Cloning and characterization of IL-1HY2, a novel interleukin-1 family member. J. Biol. Chem. 2001;276:20597\u201320602.", "ArticleIdList": ["11278614"]}, {"Citation": "van de Veerdonk FL, de Graaf DM, Joosten LA, Dinarello CA. Biology of IL-38 and its role in disease. Immunol. Rev. 2018;281:191\u2013196.", "ArticleIdList": ["29247986"]}, {"Citation": "Towne JE, et al. Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36\u03b1, IL-36\u03b2, and IL-36\u03b3) or antagonist (IL-36Ra) J. Biol. Chem. 2011;286:42594\u201342602.", "ArticleIdList": ["PMC3234937", "21965679"]}, {"Citation": "van de Veerdonk FL, et al. IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist. Proc. Natl Acad. Sci. USA. 2012;109:3001\u20133005.", "ArticleIdList": ["PMC3286950", "22315422"]}, {"Citation": "Mora J, et al. Interleukin-38 is released from apoptotic cells to limit inflammatory macrophage responses. J. Mol. Cell Biol. 2016;8:426\u2013438.", "ArticleIdList": ["26892022"]}, {"Citation": "Chu M, et al. Aberrant expression of novel cytokine IL-38 and regulatory T lymphocytes in childhood asthma. Molecules. 2016;21:933.", "ArticleIdList": ["PMC6274345", "27438823"]}, {"Citation": "Xu WD, Huang AF. Role of interleukin-38 in chronic inflammatory diseases: a comprehensive review. Front. Immunol. 2018;9:1462.", "ArticleIdList": ["PMC6023968", "29988385"]}, {"Citation": "Takenaka S, et al. IL-38: a new factor in rheumatoid arthritis. Biochem. Biophys. Rep. 2015;4:386\u2013391.", "ArticleIdList": ["PMC5669445", "29124228"]}, {"Citation": "Boutet MA, et al. IL-38 overexpression induces anti-inflammatory effects in mice arthritis models and in human macrophages in vitro. Ann. Rheum. Dis. 2017;76:1300\u20131308.", "ArticleIdList": ["28288964"]}, {"Citation": "Chu M, et al. Immunobiology in vivo anti-inflammatory activities of novel cytokine IL-38 in Murphy Roths Large (MRL)/lpr mice. Immunobiology. 2017;222:483\u2013493.", "ArticleIdList": ["27769564"]}, {"Citation": "Han Y, et al. IL-38 ameliorates skin inflammation and limits IL-17 production from \u03b3\u03b4 T cells. Cell Rep. 2019;27:835\u2013846.", "ArticleIdList": ["30995480"]}, {"Citation": "Mercurio L, et al. IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment. Cell Death Dis. 2018;9:1104.", "ArticleIdList": ["PMC6207563", "30377293"]}, {"Citation": "Xu K, et al. Hydrodynamic delivery of IL-38 gene alleviates obesity-induced inflammation and insulin resistance. Biochem. Biophys. Res. Commun. 2019;508:198\u2013202.", "ArticleIdList": ["30477747"]}, {"Citation": "Xu F, et al. Interleukin 38 protects against lethal sepsis. J. Infect. Dis. 2018;218:1175\u20131184.", "ArticleIdList": ["29762676"]}, {"Citation": "Wang Y, et al. A novel subset of CD4+TH2 memory / effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma. J. Exp. Med. 2010;207:2479\u20132491.", "ArticleIdList": ["PMC2964570", "20921287"]}, {"Citation": "Garraud T, Harel M, Boutet MA, Le Goff B, Blanchard F. The enigmatic role of IL-38 in inflammatory diseases. Cytokine Growth Factor Rev. 2018;39:26\u201335.", "ArticleIdList": ["29366546"]}, {"Citation": "Chu M, et al. In vivo anti-inflammatory activities of novel cytokine IL-38 in Murphy Roths Large (MRL)/lpr mice. Immunobiology. 2017;222:483\u2013493.", "ArticleIdList": ["27769564"]}, {"Citation": "Gorska-Ciebiada M, Ciebiada M, Gorska MM, Gorski P. Grzelewska-Rzymowska I. ICAM-1 and TNF-\u03b1 in patients with persistent asthma - relationship with the disease severity. J. Allergy Clin. Immunol. 2006;117:s258.", "ArticleIdList": ["16892784"]}, {"Citation": "Nagata M, Sedgwick JB, Bates ME, Kits H, Busse WW. Eosinophil adhesion to vascular cell adhesion molecule-1 activates superoxide anion generation. J. Immunol. 1995;155:2194\u20132102.", "ArticleIdList": ["7543540"]}, {"Citation": "Sampath D, et al. Constitutive activation of an epithelial signal transducer and activator of transcription (STAT) pathway in asthma Find the latest version: constitutive activation of an epithelial signal transducer and activator of transcription (STAT) pathway in asth. J. Clin. Invest. 1999;103:1353\u20131361.", "ArticleIdList": ["PMC408358", "10225979"]}, {"Citation": "Simeone-penney MC, et al. Airway epithelial STAT3 is required for allergic inflammation in a murine model of asthma. J. Immunol. 2007;178:6191\u20136199.", "ArticleIdList": ["17475846"]}, {"Citation": "Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 2002;298:1911\u20131912.", "ArticleIdList": ["12471242"]}, {"Citation": "Zhou H, et al. POU2AF1 functions in the human airway epithelium to regulate expression of host defense genes. J. Immunol. 2016;196:3159\u20133167.", "ArticleIdList": ["PMC4799774", "26927796"]}, {"Citation": "Bansal G, et al. RGS13 controls G-protein-coupled receptor-evoked responses of human mast cells. J. Immunol. 2008;181:7882\u20137890.", "ArticleIdList": ["PMC2693264", "19017978"]}, {"Citation": "Cho SH, Stanciu LA, Holgate ST, Johnston SL. Increased interleukin-4, interleukin-5, and interferon-gamma in airway CD4+ and CD8+ T cells in atopic asthma. Am. J. Respir. Crit. Care Med. 2005;171:224\u2013230.", "ArticleIdList": ["15502111"]}, {"Citation": "Molet S, et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J. Allergy Clin. Immunol. 2001;108:430\u2013438.", "ArticleIdList": ["11544464"]}, {"Citation": "Wong CK, et al. Activation of peripheral Th17 lymphocytes in patients with asthma. Immunol. Invest. 2009;38:652\u2013664.", "ArticleIdList": ["19811428"]}, {"Citation": "Aron JL, Akbari O. Regulatory T cells and type 2 innate lymphoid cell-dependent asthma. Allergy. 2017;72:1148\u20131155.", "ArticleIdList": ["28160290"]}, {"Citation": "Kearley J, Robinson DS, Lloyd CM. CD4+CD25+ regulatory T cells reverse established allergic airway inflammation and prevent airway remodeling. J. Allergy Clin. Immunol. 2008;122:617\u2013624.", "ArticleIdList": ["PMC3389733", "18672278"]}, {"Citation": "Dong J, et al. Amelioration of allergic airway inflammation in mice by regulatory IL-35 through dampening inflammatory dendritic cells. Allergy. 2015;70:921\u2013932.", "ArticleIdList": ["25869299"]}, {"Citation": "Timmann C, et al. Promoter haplotypes of the interleukin-10 gene influence proliferation of peripheral blood cells in response to helminth antigen. Genes Immun. 2004;5:256\u2013260.", "ArticleIdList": ["15129234"]}, {"Citation": "Li MO, Wan YY, Sanjabi S, Robertson AL, Flavell RA. Transforming growth factor-\u03b2 regulation of immune responses. Annu. Rev. Immunol. 2006;24:99\u2013146.", "ArticleIdList": ["16551245"]}, {"Citation": "Flood-page P, et al. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J. Clin. Invest. 2003;112:1029\u20131036.", "ArticleIdList": ["PMC198522", "14523040"]}, {"Citation": "Mangan PR, et al. Transforming growth factor-beta induces development of the TH 17 lineage. Nature. 2006;441:231\u2013234.", "ArticleIdList": ["16648837"]}, {"Citation": "Saradna A, Do DC, Kumar S, Fu QL, Gao P. Macrophage polarization and allergic asthma. Transl. Res. 2018;191:1\u201314.", "ArticleIdList": ["PMC5776696", "29066321"]}, {"Citation": "Robbe P, et al. Distinct macrophage phenotypes in allergic and nonallergic lung inflammation. Am. J. Physiol. Lung Cell Mol. Physiol. 2015;308:L358\u2013L367.", "ArticleIdList": ["25502502"]}, {"Citation": "Matsuoka M, et al. Attenuated airway eosinophilic inflammations in IL-38 knockout mouse model. Kurum. Med. J. 2018;65:37\u201346.", "ArticleIdList": ["30853691"]}, {"Citation": "De Sanctis GT, Daheshia M, Daser A. Genetics of airway hyperresponsiveness. J. Allergy Clin. Immunol. 2001;108:11\u201320.", "ArticleIdList": ["11447377"]}, {"Citation": "Gueders MM, et al. Mouse models of asthma: a comparison between C57BL/6 and BALB/c strains regarding bronchial responsiveness, inflammation, and cytokine production. Inflamm. Res. 2009;58:845\u2013854.", "ArticleIdList": ["19506803"]}, {"Citation": "Nials AT, Uddin S. Mouse models of allergic asthma: acute and chronic allergen challenge. Dis. Model Mech. 2008;1:213\u2013220.", "ArticleIdList": ["PMC2590830", "19093027"]}, {"Citation": "Klein Wolterink RG, et al. Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma. Eur. J. Immunol. 2012;42:1106\u20131116.", "ArticleIdList": ["22539286"]}, {"Citation": "Fujisaka S, et al. Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes. 2009;58:2574\u20132582.", "ArticleIdList": ["PMC2768159", "19690061"]}, {"Citation": "Rahman AH, Tordesillas L, Berin MC. Heparin reduces nonspecific eosinophil staining artifacts in mass cytometry experiments. Cytom. A. 2016;89:601\u2013607.", "ArticleIdList": ["PMC4919163", "27061608"]}]}], "History": [{"Year": "2019", "Month": "4", "Day": "26"}, {"Year": "2019", "Month": "9", "Day": "15"}, {"Year": "2019", "Month": "10", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "7", "Day": "29", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "10", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "10", "Day": "23"}], "PublicationStatus": "ppublish", "ArticleIdList": ["31645649", "PMC7264207", "10.1038/s41423-019-0300-7", "10.1038/s41423-019-0300-7"]}}]}